EXAGEN INC. Annual Return On Equity in % from 2018 to 2023
-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Exagen Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
- Exagen Inc. Return On Equity for the quarter ending June 30, 2024 was -78.9 %, a 6.57% increase year-over-year.
- Exagen Inc. annual Return On Equity for 2023 was -80.3 %, a 0.64% decline from 2022.
- Exagen Inc. annual Return On Equity for 2022 was -79.8 %, a 177% decline from 2021.
- Exagen Inc. annual Return On Equity for 2021 was -28.8 %, a 20.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)